Who Paid My Doc
Flumist Quadrivalent
Biological Respiratory
NDC 66019-310-10
General payments
$1,224,642
Research payments
$36,994
Through program year 2025, $1,224,642 in general payments and $36,994 in research payments were reported against Flumist Quadrivalent (Respiratory).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $51,338 | 165 |
| 2025 | Research | $13,738 | 3 |
| 2024 | General | $102,471 | 3,297 |
| 2024 | Research | $11,856 | 1 |
| 2023 | General | $1,070,834 | 3,418 |
| 2023 | Research | $11,400 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 16 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
6,880 general · 5 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.